Opportunity Information: Apply for CDC RFA PS10 10370501SUPP16
Apply for CDC RFA PS10 10370501SUPP16
- The HHS-CDC in the health sector is offering a public funding opportunity titled "Building capacity of the Pasteur Institute to provide quality laboratory diagnosis and surveillance of opportunistic infections related to HIV in the Republic of Cote d'Ivoire under the President’s Emergency Plan for AIDS Relief" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Oct 28, 2015 and posted on Oct 28, 2015.
- Applicants must submit their applications by Dec 28, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, titled "Building capacity of the Pasteur Institute to provide quality laboratory diagnosis and surveillance of opportunistic infections related to HIV in the Republic of Cote d'Ivoire under the President's Emergency Plan for AIDS Relief," is a U.S. government grant announcement from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC). It is issued under the President's Emergency Plan for AIDS Relief (PEPFAR) and focuses on improving the laboratory systems needed to diagnose and track opportunistic infections that affect people living with HIV in Cote d'Ivoire.
At its core, the grant is designed to strengthen the Pasteur Institute - Cote d'Ivoire as a central technical institution and to reinforce the broader national laboratory network that supports HIV care and treatment. The emphasis is on building capacity to deliver high-quality laboratory services for HIV-related opportunistic infections, which are infections that take advantage of weakened immune systems and can drive illness and death if they are not detected and treated promptly. In practical terms, this type of work typically includes improving diagnostic capability, ensuring laboratory quality management practices are in place, supporting reliable testing workflows, and making sure laboratory data can be used to guide clinical decisions and public health action.
A major component of the opportunity is surveillance and performance oversight at the national or central level. The announcement explicitly highlights implementing central-level surveillance, monitoring, and evaluation of laboratory activities. That means the award is not only about improving test capacity in one facility; it is also about establishing or enhancing systems that can track laboratory performance, test results trends, and program indicators across the network. This kind of centralized monitoring and evaluation helps public health leaders understand where opportunistic infections are occurring, whether laboratories are producing accurate and timely results, and what gaps exist in supplies, staffing, training, or quality assurance. It also supports accountability by making laboratory activities measurable and comparable over time.
The CDC plans to support this work through a cooperative agreement, which generally means the recipient would carry out the project while working closely with CDC staff who may provide substantial programmatic involvement, technical guidance, and oversight compared with a standard grant. The opportunity is categorized as discretionary funding within the health activity area and is associated with CFDA number 93.067, which corresponds to CDC's HIV-related assistance and prevention programs. The funding opportunity number is CDC RFA PS10-10370501SUPP16.
In terms of scale and competition, the announcement anticipates a single award (ExpectedAwards: 1) with an award ceiling of $1,000,000. The posting date and creation date are both October 28, 2015, and the closing date for applications is December 28, 2015, indicating a defined submission window. Eligibility is listed as "Others (see text field entitled Additional Information on Eligibility for clarification)," which signals that eligibility may be limited or specialized and would normally require checking the full eligibility language in the official notice to confirm who can apply (for example, specific institutions, organizations with certain capabilities, or entities with an existing relationship to the program).
Overall, the grant opportunity is aimed at improving the quality, consistency, and public health usefulness of laboratory services for HIV-related opportunistic infections in Cote d'Ivoire by reinforcing the Pasteur Institute's role and strengthening the national laboratory network. It ties laboratory diagnosis directly to surveillance and program monitoring, reflecting the reality that better testing is most valuable when results are reliable, timely, and translated into actionable information for clinicians and national HIV program leaders.
Frequently Asked Questions (FAQs)
What is the title of this funding opportunity?
The opportunity is titled "Building capacity of the Pasteur Institute to provide quality laboratory diagnosis and surveillance of opportunistic infections related to HIV in the Republic of Cote d'Ivoire under the President's Emergency Plan for AIDS Relief."
Which U.S. government agency is offering this grant?
This is a U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC) funding opportunity.
Is this opportunity connected to PEPFAR?
Yes. The announcement is issued under the President's Emergency Plan for AIDS Relief (PEPFAR).
What country and institution are the focus of this opportunity?
The work is focused on the Republic of Cote d'Ivoire and specifically aims to strengthen the Pasteur Institute - Cote d'Ivoire as a central technical institution, while also reinforcing the broader national laboratory network supporting HIV care and treatment.
What is the main purpose of the grant?
The main purpose is to improve laboratory systems needed to diagnose and track opportunistic infections related to HIV in Cote d'Ivoire by building capacity for high-quality laboratory diagnosis and surveillance.
What are "opportunistic infections" in the context of this announcement?
In this announcement, opportunistic infections are infections that take advantage of weakened immune systems in people living with HIV and can contribute to illness and death if not detected and treated promptly.
What types of activities does the opportunity emphasize?
The opportunity emphasizes strengthening laboratory capacity to deliver high-quality services for HIV-related opportunistic infections. Practical areas highlighted include improving diagnostic capability, implementing laboratory quality management practices, supporting reliable testing workflows, and ensuring laboratory data can guide clinical decisions and public health action.
Does the grant focus only on a single laboratory facility?
No. While strengthening the Pasteur Institute - Cote d'Ivoire is central, the announcement also emphasizes reinforcing the broader national laboratory network and supporting central-level systems that monitor activities across the network.
What does "central-level surveillance, monitoring, and evaluation" mean here?
It refers to implementing national or central oversight systems to track laboratory performance, test-result trends, and program indicators across the laboratory network. The intent is to help leaders understand where opportunistic infections are occurring, whether labs are producing accurate and timely results, and where gaps exist (such as supplies, staffing, training, or quality assurance).
How does this opportunity link laboratory testing to public health action?
The announcement highlights that testing is most valuable when results are reliable and timely and can be translated into actionable information for clinicians and national HIV program leaders. The surveillance and monitoring components are designed to make laboratory work measurable and useful for decision-making.
What funding mechanism will CDC use for this award?
CDC plans to support the work through a cooperative agreement.
What does a "cooperative agreement" imply for how the project is carried out?
As described in the announcement, a cooperative agreement generally means the recipient would carry out the project while working closely with CDC staff, who may provide substantial programmatic involvement, technical guidance, and oversight compared with a standard grant.
What is the CFDA number associated with this opportunity?
The CFDA number listed is 93.067, which corresponds to CDC's HIV-related assistance and prevention programs.
What is the funding opportunity number?
The funding opportunity number is CDC RFA PS10-10370501SUPP16.
How many awards does CDC expect to make?
The announcement anticipates a single award (ExpectedAwards: 1).
What is the maximum award amount (award ceiling)?
The award ceiling listed in the announcement is $1,000,000.
What is the application posting date for this opportunity?
The posting date (and creation date) is October 28, 2015.
What is the application deadline?
The closing date for applications is December 28, 2015.
What is the eligibility category listed in the announcement?
Eligibility is listed as "Others (see text field entitled Additional Information on Eligibility for clarification)."
Does the eligibility statement fully specify who can apply?
No. The eligibility line indicates that additional clarification would normally be found in the "Additional Information on Eligibility" section of the official notice, and that eligibility may be limited or specialized.
What general outcomes is this opportunity aiming to support?
Based on the announcement, the intended outcomes are improved quality, consistency, and public health usefulness of laboratory services for HIV-related opportunistic infections in Cote d'Ivoire, strengthened central technical capacity at the Pasteur Institute - Cote d'Ivoire, and improved surveillance and performance oversight across the national laboratory network.
What broad program area does this opportunity fall under?
The opportunity is categorized as discretionary funding within the health activity area and is associated with CDC HIV-related assistance and prevention programming.
Browse more opportunities from the same category: Health
Next opportunity: Evaluating Locally-Developed or Adapted (Homegrown) Combination HIV Prevention Interventions for Transgender Persons who have Sex with Men
Previous opportunity: Ocean Acidification at Glacier Bay National Park Preserve
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS10 10370501SUPP16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS10 10370501SUPP16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Evaluating Locally-Developed or Adapted (Homegrown) Combination HIV Prevention Interventions for Transgender Persons who have Sex with Men Apply for RFA PS 16 003 Funding Number: RFA PS 16 003 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $200,000 |
| Grants to States to Support Oral Health Workforce Activities Apply for HRSA 16 038 Funding Number: HRSA 16 038 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Supporting the Implementation and Expansion of High Quality, Sustainable and Comprehensive HIV Prevention, Care and Treatment Programs in the Eastern South Region and Nairobi County of the Republic of Kenya under the President’s Emergency Plan for Apply for CDC RFA GH16 1701 Funding Number: CDC RFA GH16 1701 Agency: HHS-CDC-CGH Category: Health Funding Amount: $22,000,000 |
| Capacity Building and Strengthening Implementation of HIV Combination Prevention and Treatment Services in Priority Geographic Locations and Populations at Facility, Community, District and Provincial Levels in the Republic of Zambia under the Presid Apply for CDC RFA GH16 1670 Funding Number: CDC RFA GH16 1670 Agency: HHS-CDC-CGH Category: Health Funding Amount: $20,000,000 |
| Emerging Infections Sentinel Networks (EISN) Research Apply for RFA CK 16 001 Funding Number: RFA CK 16 001 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: Case Dependent |
| Provision of Comprehensive HIV Care, Treatment, and Support Programs in the United Republic of Tanzania under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1653 Funding Number: CDC RFA GH16 1653 Agency: HHS-CDC-CGH Category: Health Funding Amount: $9,422,167 |
| Suicide Prevention Lifeline Crisis Center Follow-Up Apply for SM 16 006 Funding Number: SM 16 006 Agency: HHS-SAMHS Category: Health Funding Amount: $115,000 |
| Accelerating the Scale-Up of Voluntary Medical Male Circumcision for HIV Prevention for Maximum Public Health Impact in the United Republic of Tanzania under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1647 Funding Number: CDC RFA GH16 1647 Agency: HHS-CDC-CGH Category: Health Funding Amount: $9,000,000 |
| Statewide Consumer Network Program Apply for SM 16 002 Funding Number: SM 16 002 Agency: HHS-SAMHS Category: Health Funding Amount: $95,000 |
| Shared Instrumentation Grant (SIG) Program (S10) Apply for PAR 16 054 Funding Number: PAR 16 054 Agency: HHS-NIH11 Category: Health Funding Amount: $600,000 |
| Ryan White HIV/AIDS Program Integrated HIV Planning Implementation Apply for HRSA 16 082 Funding Number: HRSA 16 082 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Supporting the Ministry of Health, County Health Management Teams, and Service Delivery Partners in Developing and Maintaining Health Information Systems Innovations in the Republic of Kenya under the President’s Emergency Plan for AIDS Relief (PEP Apply for CDC RFA GH16 1628 Funding Number: CDC RFA GH16 1628 Agency: HHS-CDC-CGH Category: Health Funding Amount: $5,000,000 |
| Cooperative Agreement for the Provider’s Clinical Support System - Medication Assisted Treatment (Short Title: PCSS-MAT) Apply for TI 16 003 Funding Number: TI 16 003 Agency: HHS-SAMHS Category: Health Funding Amount: $1,000,000 |
| Pre-travel Health Preparation of International Travelers: Expanding and Improving Data Collection, Guidance, and Outreach Apply for RFA CK 16 003 Funding Number: RFA CK 16 003 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $800,000 |
| Services Research for Autism Spectrum Disorders across the Lifespan II (ServASD II): Pilot Studies of Services Strategies for Adults with ASD (R34) Apply for RFA MH 17 205 Funding Number: RFA MH 17 205 Agency: HHS-NIH11 Category: Health Funding Amount: $225,000 |
| Health Center Controlled Networks Apply for HRSA 16 010 Funding Number: HRSA 16 010 Agency: HHS-HRSA Category: Health Funding Amount: $1,500,000 |
| Michigan Lupus Epidemiology and Surveillance (MILES) Program Longitudinal Cohort Study Apply for RFA DP 16 002 Funding Number: RFA DP 16 002 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $1,000,000 |
| Research on Prescription Opioid Use, Opioid Prescribing, and Associated Heroin Risk. Apply for RFA CE 16 003 Funding Number: RFA CE 16 003 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $400,000 |
| Centers for Disease Control and Prevention Natural History and Prevention of Viral Hepatitis among Alaska Natives Project. Apply for RFA PS 13 00104CONT16 Funding Number: RFA PS 13 00104CONT16 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: Case Dependent |
| Supporting Sustainable Implementation of HIV and TB Services for Epidemic Control in The Republic of Mozambique under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1634 Funding Number: CDC RFA GH16 1634 Agency: HHS-CDC-CGH Category: Health Funding Amount: $165,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS10 10370501SUPP16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.